Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neoadjuvant therapy in high‑risk adult patients with soft tissue sarcoma
2004-002501-72Phase 2Active
- Start
- Oct 2004
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of etoposide, ifosfamide and doxorubicin in soft tissue sarcoma (STS). Primary endpoint: disease-free survival. Started Oct 2004; status: active.
02
Drugs
etoposideifosfamidedoxorubicin
03
Conditions
soft tissue sarcoma (STS)
Beyond the preview
Go deeper on 2004-002501-72.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-002501-72.